ELIZABETH GARCIA: Open Payments
NPI 1538749601 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$149 in 7 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $22 · 2025 $149
Food & beverage: $149
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $58 |
| Lilly USA, LLC | 1 | $28 |
| ABBVIE INC. | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: Fabhalta, JARDIANCE, EPKINLY, LOKELMA, BENLYSTA.
Industry payments across CO — which companies pay providers there.
